These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10375291)

  • 1. Impact of glucose control in type 2 diabetes: session summary.
    Stern MP
    Diabetes Care; 1999 Apr; 22 Suppl 3():C57-60. PubMed ID: 10375291
    [No Abstract]   [Full Text] [Related]  

  • 2. Unanswered questions arising from the continuous relationship between glucometabolic state and cardiovascular risk.
    Tonkin AM; Chen L
    Curr Atheroscler Rep; 2006 Nov; 8(6):439-40. PubMed ID: 17045067
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-hour postload plasma glucose levels, a predictor of additional risk for diabetes: prevalence, mechanisms, and associated cardiovascular and metabolic risk factors in Hispanics.
    Cubeddu LX; Hoffmann IS
    Metab Syndr Relat Disord; 2010 Oct; 8(5):395-402. PubMed ID: 20854093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
    Karasik A
    Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study.
    Cavalot F; Petrelli A; Traversa M; Bonomo K; Fiora E; Conti M; Anfossi G; Costa G; Trovati M
    J Clin Endocrinol Metab; 2006 Mar; 91(3):813-9. PubMed ID: 16352690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancy.
    Bajaj HS; Ye C; Hanley AJ; Sermer M; Zinman B; Retnakaran R
    Diab Vasc Dis Res; 2018 Sep; 15(5):449-457. PubMed ID: 29871496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
    Quispe R; Martin SS; Jones SR
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying a Big Data Approach to Biomarker Discovery: Running Before We Walk?
    de Lemos JA; Rohatgi A; Ayers CR
    Circulation; 2015 Dec; 132(24):2289-92. PubMed ID: 26518764
    [No Abstract]   [Full Text] [Related]  

  • 10. [Does the strict blood glucose control worsen cardiovascular risk in type 2 diabetes ?].
    Tambascia M
    Rev Assoc Med Bras (1992); 2008; 54(1):1. PubMed ID: 18392469
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of postprandial hyperglycemia in the development of cardiovascular diseases in type 2 diabetes mellitus].
    Shvarts V
    Klin Med (Mosk); 2009; 87(11):17-24. PubMed ID: 20143560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Prim Care Diabetes; 2007 Jun; 1(2):69-74. PubMed ID: 18632022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Should we prescribe regular physical activity for patients presenting with type 2 diabetes?].
    Gautier JF
    Diabete Metab; 1994; 20(5):497-500. PubMed ID: 7859899
    [No Abstract]   [Full Text] [Related]  

  • 14. Postprandial glucose: marker or risk factor?
    Avogaro A
    Diabetes Care; 2011 Oct; 34(10):2333-5. PubMed ID: 21949226
    [No Abstract]   [Full Text] [Related]  

  • 15. A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.
    Heald AH; Knapman H; Nair S; Chambers T; Radford D; Rushton T; Anderson SG
    Prim Care Diabetes; 2012 Oct; 6(3):213-9. PubMed ID: 22560663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 17. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
    Sherman FT
    Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 19. A Practical Guide to the Use of Glucose-Lowering Agents With Cardiovascular Benefit or Proven Safety.
    Fitchett D; Cheng A; Connelly K; Goldenberg R; Goodman SG; Leiter LA; Lonn E; Paty B; Poirier P; Stone J; Thompson D; Yale JF; Mancini GBJ
    Can J Cardiol; 2017 Jul; 33(7):940-942. PubMed ID: 28668144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy and clinical trials: glycaemic control and cardiovascular disease.
    Edavalath M; Rees A
    Curr Opin Lipidol; 2009 Dec; 20(6):530-1. PubMed ID: 19935205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.